Loading…

A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes

Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; how...

Full description

Saved in:
Bibliographic Details
Published in:International journal of neonatal screening 2022-03, Vol.8 (2), p.25
Main Authors: Burlina, Alberto, Jones, Simon A, Chakrapani, Anupam, Church, Heather J, Heales, Simon, Wu, Teresa H Y, Morton, Georgina, Roberts, Patricia, Sluys, Erica F, Cheillan, David
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3
cites cdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3
container_end_page
container_issue 2
container_start_page 25
container_title International journal of neonatal screening
container_volume 8
creator Burlina, Alberto
Jones, Simon A
Chakrapani, Anupam
Church, Heather J
Heales, Simon
Wu, Teresa H Y
Morton, Georgina
Roberts, Patricia
Sluys, Erica F
Cheillan, David
description Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.
doi_str_mv 10.3390/ijns8020025
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_db98af22eefe43c787d56700ed2973ef</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_db98af22eefe43c787d56700ed2973ef</doaj_id><sourcerecordid>2679738116</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</originalsourceid><addsrcrecordid>eNpdkl1rFDEUhgdRbKm98l4CXupqPieTG2Fpq11YraCCdyHJnOxmmJlsk5mV_nujW8tWCCQkT56TE96qeknwO8YUfh-6MTeYYkzFk-qUcqwWgoifT4_WJ9V5zh3GmAgumWTPqxMmeF0TVZ9Wt0v0BX6h5W6XonFbNEV0YztwU9hDf4eu9qafzQRoNW4hhQla9BkmY2MfHLoMGUyGjHxMBXD9nEMcURlFaWMa0TeXAMYwbtDXFDfJDAPkF9Uzb_oM5_fzWfXj49X3i-vF-ubT6mK5Xjgu1bSQNeGENJa4xrVENY4S6z0IBRaEF6rhQlCCGzDCSGokI-Al9wrAWm9Ny86q1cHbRtPpXQqDSXc6mqD_bsS00SZNwfWgW6sa4ykF8MCZk41sRS0xhpYqycAX14eDazfbAVoH45RM_0j6-GQMW72Je60wqykXRfD2INj-d-16udZhzJAGjZkUvHS6JwV_fV8vxdsZ8qS7OKexfJemtSxvagipC_XmQLkUc07gH8wE6z_p0EfpKPSr4x4e2H9ZYL8BkE63vw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2679738116</pqid></control><display><type>article</type><title>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Burlina, Alberto ; Jones, Simon A ; Chakrapani, Anupam ; Church, Heather J ; Heales, Simon ; Wu, Teresa H Y ; Morton, Georgina ; Roberts, Patricia ; Sluys, Erica F ; Cheillan, David</creator><creatorcontrib>Burlina, Alberto ; Jones, Simon A ; Chakrapani, Anupam ; Church, Heather J ; Heales, Simon ; Wu, Teresa H Y ; Morton, Georgina ; Roberts, Patricia ; Sluys, Erica F ; Cheillan, David</creatorcontrib><description>Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.</description><identifier>ISSN: 2409-515X</identifier><identifier>EISSN: 2409-515X</identifier><identifier>DOI: 10.3390/ijns8020025</identifier><identifier>PMID: 35466196</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Algorithms ; Disease ; Fatalities ; inherited disorder ; inherited metabolic disease ; Life Sciences ; Medical screening ; Metabolic disorders ; newborn screening (NBS) ; paediatrics ; Principles ; Public health ; rare diseases</subject><ispartof>International journal of neonatal screening, 2022-03, Vol.8 (2), p.25</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</citedby><cites>FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</cites><orcidid>0000-0001-7724-137X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2679738116/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2679738116?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,44569,53769,53771,74872</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35466196$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://inserm.hal.science/inserm-03754198$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Burlina, Alberto</creatorcontrib><creatorcontrib>Jones, Simon A</creatorcontrib><creatorcontrib>Chakrapani, Anupam</creatorcontrib><creatorcontrib>Church, Heather J</creatorcontrib><creatorcontrib>Heales, Simon</creatorcontrib><creatorcontrib>Wu, Teresa H Y</creatorcontrib><creatorcontrib>Morton, Georgina</creatorcontrib><creatorcontrib>Roberts, Patricia</creatorcontrib><creatorcontrib>Sluys, Erica F</creatorcontrib><creatorcontrib>Cheillan, David</creatorcontrib><title>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</title><title>International journal of neonatal screening</title><addtitle>Int J Neonatal Screen</addtitle><description>Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.</description><subject>Algorithms</subject><subject>Disease</subject><subject>Fatalities</subject><subject>inherited disorder</subject><subject>inherited metabolic disease</subject><subject>Life Sciences</subject><subject>Medical screening</subject><subject>Metabolic disorders</subject><subject>newborn screening (NBS)</subject><subject>paediatrics</subject><subject>Principles</subject><subject>Public health</subject><subject>rare diseases</subject><issn>2409-515X</issn><issn>2409-515X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkl1rFDEUhgdRbKm98l4CXupqPieTG2Fpq11YraCCdyHJnOxmmJlsk5mV_nujW8tWCCQkT56TE96qeknwO8YUfh-6MTeYYkzFk-qUcqwWgoifT4_WJ9V5zh3GmAgumWTPqxMmeF0TVZ9Wt0v0BX6h5W6XonFbNEV0YztwU9hDf4eu9qafzQRoNW4hhQla9BkmY2MfHLoMGUyGjHxMBXD9nEMcURlFaWMa0TeXAMYwbtDXFDfJDAPkF9Uzb_oM5_fzWfXj49X3i-vF-ubT6mK5Xjgu1bSQNeGENJa4xrVENY4S6z0IBRaEF6rhQlCCGzDCSGokI-Al9wrAWm9Ny86q1cHbRtPpXQqDSXc6mqD_bsS00SZNwfWgW6sa4ykF8MCZk41sRS0xhpYqycAX14eDazfbAVoH45RM_0j6-GQMW72Je60wqykXRfD2INj-d-16udZhzJAGjZkUvHS6JwV_fV8vxdsZ8qS7OKexfJemtSxvagipC_XmQLkUc07gH8wE6z_p0EfpKPSr4x4e2H9ZYL8BkE63vw</recordid><startdate>20220325</startdate><enddate>20220325</enddate><creator>Burlina, Alberto</creator><creator>Jones, Simon A</creator><creator>Chakrapani, Anupam</creator><creator>Church, Heather J</creator><creator>Heales, Simon</creator><creator>Wu, Teresa H Y</creator><creator>Morton, Georgina</creator><creator>Roberts, Patricia</creator><creator>Sluys, Erica F</creator><creator>Cheillan, David</creator><general>MDPI AG</general><general>MDPI</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-7724-137X</orcidid></search><sort><creationdate>20220325</creationdate><title>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</title><author>Burlina, Alberto ; Jones, Simon A ; Chakrapani, Anupam ; Church, Heather J ; Heales, Simon ; Wu, Teresa H Y ; Morton, Georgina ; Roberts, Patricia ; Sluys, Erica F ; Cheillan, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Algorithms</topic><topic>Disease</topic><topic>Fatalities</topic><topic>inherited disorder</topic><topic>inherited metabolic disease</topic><topic>Life Sciences</topic><topic>Medical screening</topic><topic>Metabolic disorders</topic><topic>newborn screening (NBS)</topic><topic>paediatrics</topic><topic>Principles</topic><topic>Public health</topic><topic>rare diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Burlina, Alberto</creatorcontrib><creatorcontrib>Jones, Simon A</creatorcontrib><creatorcontrib>Chakrapani, Anupam</creatorcontrib><creatorcontrib>Church, Heather J</creatorcontrib><creatorcontrib>Heales, Simon</creatorcontrib><creatorcontrib>Wu, Teresa H Y</creatorcontrib><creatorcontrib>Morton, Georgina</creatorcontrib><creatorcontrib>Roberts, Patricia</creatorcontrib><creatorcontrib>Sluys, Erica F</creatorcontrib><creatorcontrib>Cheillan, David</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>International journal of neonatal screening</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Burlina, Alberto</au><au>Jones, Simon A</au><au>Chakrapani, Anupam</au><au>Church, Heather J</au><au>Heales, Simon</au><au>Wu, Teresa H Y</au><au>Morton, Georgina</au><au>Roberts, Patricia</au><au>Sluys, Erica F</au><au>Cheillan, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes</atitle><jtitle>International journal of neonatal screening</jtitle><addtitle>Int J Neonatal Screen</addtitle><date>2022-03-25</date><risdate>2022</risdate><volume>8</volume><issue>2</issue><spage>25</spage><pages>25-</pages><issn>2409-515X</issn><eissn>2409-515X</eissn><abstract>Newborn screening (NBS) programmes are essential in the diagnosis of inherited metabolic diseases (IMDs) and for access to disease modifying treatment. Most European countries follow the World Health Organisation (WHO) criteria to determine which disorders are appropriate for screening at birth; however, these criteria are interpreted and implemented by individual countries differently, creating disparities. Advances in research and diagnostics, together with the promise of new treatments, offer new possibilities to accelerate the expansion of evidence-based screening programmes. A novel and robust algorithm was built to objectively assess and prioritise IMDs for inclusion in NBS programmes. The Wilson and Jungner classic screening principles were used as a foundation to develop individual and measurable criteria. The proposed algorithm is a point-based system structured upon three pillars: condition, screening, and treatment. The algorithm was tested by applying the six IMDs currently approved in the United Kingdom NBS programme. The algorithm generates a weight-based score that could be used as the first step in the complex process of evaluating disorders for inclusion on NBS programmes. By prioritising disorders to be further evaluated, individual countries are able to assess the economic, societal and political aspects of a potential screening programme.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>35466196</pmid><doi>10.3390/ijns8020025</doi><orcidid>https://orcid.org/0000-0001-7724-137X</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2409-515X
ispartof International journal of neonatal screening, 2022-03, Vol.8 (2), p.25
issn 2409-515X
2409-515X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_db98af22eefe43c787d56700ed2973ef
source Publicly Available Content Database; PubMed Central
subjects Algorithms
Disease
Fatalities
inherited disorder
inherited metabolic disease
Life Sciences
Medical screening
Metabolic disorders
newborn screening (NBS)
paediatrics
Principles
Public health
rare diseases
title A New Approach to Objectively Evaluate Inherited Metabolic Diseases for Inclusion on Newborn Screening Programmes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T21%3A47%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20New%20Approach%20to%20Objectively%20Evaluate%20Inherited%20Metabolic%20Diseases%20for%20Inclusion%20on%20Newborn%20Screening%20Programmes&rft.jtitle=International%20journal%20of%20neonatal%20screening&rft.au=Burlina,%20Alberto&rft.date=2022-03-25&rft.volume=8&rft.issue=2&rft.spage=25&rft.pages=25-&rft.issn=2409-515X&rft.eissn=2409-515X&rft_id=info:doi/10.3390/ijns8020025&rft_dat=%3Cproquest_doaj_%3E2679738116%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c479t-7614118b1c8cd198c21bffe59ebe5f5984552108ea5a72a731ef74f9eebbfbad3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2679738116&rft_id=info:pmid/35466196&rfr_iscdi=true